NASDAQ · Drug Manufacturers - Specialty & Generic · USD
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Analysis
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is a Drug Manufacturers - Specialty & Generic stock listed on NASDAQ and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
SHPH Key Statistics
As of Oct 21, 2026Trading
- Open
- $4.90
- Previous Close
- $4.91
- Day's Range
- 4.76–4.95
- 52-Week Range
- 2.58–44.40
- Volume
- 6.19K
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 1.14
Valuation
- Market Cap
- $22.97M
- P/E Ratio
- unprofitable
- EPS (ttm)Profit attributable to each share over the last twelve months.
- −16.87
Financials (FY)
- Revenue (FY)
- $0.00
- Net Income (FY)
- −$11.72M
- Shares Outstanding
- 4.76M
- 1-Year Return
- −86.11%
Dividend and dates
- Avg Volume
- 130.74K
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, SHPH closed at $4.82, −86.11% over 1 year.
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) has a market capitalization of $22.97M.
In fiscal 2025, SHPH reported revenue of $0.00.
SHPH Stock Return by Calendar Year
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) return since Aug 2022: what $10,000 became
- 1 year
- $10,000 $1,389
- −86.11%
- 3 years
- $10,000 $42
- −99.58%
- Since Aug 2022
- $10,000 $0.63
- −99.99%
If you had invested $10,000 in Shuttle Pharmaceuticals Holdings, Inc. (SHPH) at the close on August 31, 2022, the earliest close on record here, it would have been worth $0.63 at the close on October 21, 2026: −99.99% in total, −90.35% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −73.22% |
| 2025 | −91.62% |
| 2024 | −76.40% |
| 2023 | −76.79% |
| 2022 (partial year) | −94.91% |
As of October 21, 2026.
SHPH Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $0.00 | −$11.72M | — |
| 2024 | $0.00 | −$9.14M | — |
| 2023 | $0.00 | −$6.59M | — |
| 2022 | $0.00 | −$5.00M | — |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $0.00 | — | −$11.92M | −$11.72M | — |
| 2024 | $0.00 | — | −$7.70M | −$9.14M | — |
| 2023 | $0.00 | — | −$5.89M | −$6.59M | — |
| 2022 | $0.00 | — | −$2.34M | −$5.00M | — |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
Recent News
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related Drug Manufacturers - Specialty & Generic Stocks
Takeda Pharmaceutical Company Limited
$63.67B
TEVATeva Pharmaceutical Industries Limited
$47.37B
HLNHaleon plc
$44.06B
ZTSZoetis Inc.
$32.90B
UTHRUnited Therapeutics Corporation
$24.17B
VTRSViatris Inc.
$21.19B
Popular Healthcare Stocks
Eli Lilly and Company
$1.13T
JNJJohnson & Johnson
$621.22B
ABBVAbbVie Inc.
$503.27B
UNHUnitedHealth Group Incorporated
$374.30B
MRKMerck & Co., Inc.
$369.78B